Symposium: Advancing regenerative medicine with silicon-based technologies

*Japanese page

Join imec, LINK-J, RISE-A, and JSRM at this health symposium on how integrated systems can make workflows more data-driven, automated, and precise. 

Event summary

Regenerative medicine and cell therapy face unique challenges: biological variability, limited scalability, complex cell handling, and insufficient quality control. To tackle these issues, imec leverages its semiconductor expertise to provide silicon-enabled solutions that bring automation, precision, and reproducibility to research, development, and manufacturing.

Imec's technology portfolio includes:

Advanced cell sorting concepts: high-throughput, label-free, multi-marker selection using microfluidic and photonic platforms.
Integrated multi-electrode systems: high-density microelectrode arrays for precise electroporation
Integrated multi-sensor systems: for real-time monitoring of cell cultures
On-chip molecular analysis enabling DNA, RNA, protein etc. analysis
Computational imaging: label-free, high-resolution imaging systems for scalable quality control of living cells.
These modular technologies can be integrated across regenerative medicine and cell therapy workflows - from cell isolation and expansion to culture monitoring and quality control - helping to standardize processes, support scalable production, and accelerate translation from research to therapy.

Imec works closely with industry partners to co-develop custom solutions, demonstrating how silicon technology can enhance precision, reproducibility, and scalability in regenerative therapy development.